http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018213813-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6eca83dd237a3986aefdfc1078c3b029
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
filingDate 2018-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d60ccf3333812fb3ca4dc6359b735060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14a4989fa329ea85a9f2cacd5d87430b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ec3ed4d403d1dbd47ac07d6c78da1c8
publicationDate 2019-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018213813-A3
titleOfInvention Psychotropic agents and uses thereof
abstract The R enantiomer of amisulpride and amisulpride derivative disclosed herein or a pharmaceutical composition thereof may be used for antagonizing serotonin (e.g., 5-HT2a, 5-HT7) receptor in a subject, either individually or in combination with other CNS active agents. The R enantiomer of amisulpride and amisulpride derivative disclosed herein or a pharmaceutical composition thereof may be used for treating one or more conditions responsive to modulation of serotonin (e.g., 5-HT2a, 5-HT7) receptor in a subject, either individually or in combination with other CNS active agents. The R enantiomer of amisulpride and amisulpride derivative disclosed herein or a pharmaceutical composition thereof may be used for treating one or more disorders associated with an abnormality in levels of serotonin in the brain, either individually or in combination with other CNS active agents.
priorityDate 2017-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4210660-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6069165-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2159
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420646

Total number of triples: 24.